Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2009-08-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this pilot study is to determine if the SmartPill can detect a change in transit time using a significant dose of dietary fiber.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Whole Gut Transit Time Using the SmartPill Capsule
NCT00603707
Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit
NCT04210427
Fibers and Gut Health
NCT02234518
Validation of New Type Radiopaque Marker in The Evaluation of Colonic Transit Time
NCT06850415
Colonic Transit Time Validation Study
NCT00857363
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low fiber and High Fiber
Subjects consume a low fiber cereal and swallow the SmartPill device that measures gastrointestinal transit time Subjects consume a high fiber cereal along with swallowing the SmartPill device that measures gastrointestinal transit time
SmartPill
SmartPill
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SmartPill
SmartPill
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 - 65
* Non-smoking
* Not taking medication
* Non-dieting
* BMI 18-30
* English literacy
* Ability to swallow the SmartPill
Exclusion Criteria
* Food allergies to ingredients fond in study products
* Dislike of hot cereal
* BMI \<18 or \>30
* Are not weight stable
* Diagnosed with diabetes, cardiovascular, renal, or hepatic disease
* Cancer in previous 5 years (except basal cell carinoma of the skin)
* Any gastrointestinal disease or condition
* Any gastrointestinal surgeries that alter motility
* Recent antibiotic usage (\< 6 months)
* recent or concurrent participation in an intervention research study
* History of drug or alcohol abuse in prior 6 months
* Use of laxatives, anti-diarrheal, antacids, or medications which alter motility
* Vegetarians
* People who eat more than approximately 15 grams of fiber per day
* Currently consume fiber supplements
* Women who are pregnant or lactating
* Women with irregular menstrual cycles
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Mills
INDUSTRY
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanne L Slavin, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota - McNeal Hall
Saint Paul, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Timm D, Willis H, Thomas W, Sanders L, Boileau T, Slavin J. The use of a wireless motility device (SmartPill(R)) for the measurement of gastrointestinal transit time after a dietary fibre intervention. Br J Nutr. 2011 May;105(9):1337-42. doi: 10.1017/S0007114510004988. Epub 2010 Dec 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0903M60781
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.